Table 2.
HMGB1 levels, Doppler-echocardiography and cardiopulmonary parameters of the study population (n = 67).
| HMGB1 (ng/ml) | 14.6 ± 6.7 |
| LVIVSd (mm) | 10.8 ± 1.9 |
| LVPWTd (mm) | 11.2 ± 2.2 |
| LA dimension (mm) | 39.6 ± 2.4 |
| LVEDV (ml/m2) | 48.4 ± 6.9 |
| LVESV (ml/m2) | 31.3 ± 7.4 |
| LVEF (%) | 47.7 ± 6.9 |
| Peak E-wave velocity (cm/s) | 59.5 ± 7.0 |
| E/A ratio | 0.94 ± 0.2 |
| Systolic Blood Pressure (mmHg) | 120 ± 9 |
| Diastolic Blood Pressure (mmHg) | 76 ± 5 |
| Resting Heart Rate (beats/min) | 77 ± 5 |
| VO2peak (ml/kg/min) | 14.4 ± 4.1 |
| VE/VCO2slope | 31.9 ± 6.0 |
| Heart Rate Recovery (beats/min) | 20 ± 4 |
Data are expressed in mean ± standard deviation.
Abbreviations: HMGB1, high mobility group box-1 protein; LA, left atrium; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; LVIVSd, diastolic left ventricular interventricular septum; LVPWTd, left ventricular posterior wall thickness; VO2peak, oxygen consumption at peak exercise; VE/VCO2slope, slope of increase in ventilation over carbon dioxide output.